BioMedAI  ·  Agent Set 2

AI Drug Design

AI Drug Design takes validated targets from AI Target Discovery and applies generative AI to design, screen, and optimize candidate molecules — reasoning over structure-activity relationships, ADMET profiles, and synthesis feasibility.

In Development
70%
Stage 2
Follows AI Target Discovery target research output
AI Target Discovery — Live AI Drug Design — In Dev AI Drug Design is Stage 2 of the BioMedAI pipeline — it receives target validation outputs from AI Target Discovery and applies generative AI to molecule design.

From Validated Target to Lead Candidate

AI Drug Design agents orchestrate the full small molecule and biologics design loop with continuous optimization.

1. Target Input
Input requested drug targets and user constraints.
2. Molecule Generation
Generate candidate molecules optimized for binding affinity and selectivity.
3. Developability Screening
Each candidate is scored and filtered for developability prediction.
4. Lead Ranking
Top candidates are ranked by multi-parameter optimization and synthesis feasibility score.

What AI Drug Design Delivers

In Development

Get Early Access to AI Drug Design

We're working with select biopharma teams to co-develop AI Drug Design's capabilities. If you have a drug design challenge, we'd like to hear from you.

Book a Discovery Call

Start with AI Target Discovery While AI Drug Design Launches

AI Target Discovery is live today. Get your target research automated now — and be first in line when AI Drug Design ships.